We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT01470716
Brief Title: Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations

First Submitted : November 4, 2011
First Submitted that Met QC Criteria : November 10, 2011
First Posted : November 11, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : April 4, 2022
Last Update Posted : April 6, 2022